- Home
- AQST vs GHI Comparison
AQST vs GHI Comparison
Compare AQST & GHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- GHI
- Stock Information
- Founded
- AQST 2004
- GHI 1998
- Country
- AQST United States
- GHI United States
- Employees
- AQST N/A
- GHI N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- GHI Finance: Consumer Services
- Sector
- AQST Health Care
- GHI Finance
- Exchange
- AQST Nasdaq
- GHI Nasdaq
- Market Cap
- AQST 272.9M
- GHI 269.5M
- IPO Year
- AQST 2018
- GHI N/A
- Fundamental
- Price
- AQST $4.06
- GHI $11.51
- Analyst Decision
- AQST Strong Buy
- GHI Strong Buy
- Analyst Count
- AQST 7
- GHI 4
- Target Price
- AQST $11.29
- GHI $16.00
- AVG Volume (30 Days)
- AQST 1.3M
- GHI 52.4K
- Earning Date
- AQST 08-05-2025
- GHI 08-06-2025
- Dividend Yield
- AQST N/A
- GHI 13.03%
- EPS Growth
- AQST N/A
- GHI N/A
- EPS
- AQST N/A
- GHI 0.45
- Revenue
- AQST $54,228,000.00
- GHI $34,065,322.00
- Revenue This Year
- AQST N/A
- GHI $228.92
- Revenue Next Year
- AQST $45.71
- GHI $4.27
- P/E Ratio
- AQST N/A
- GHI $25.38
- Revenue Growth
- AQST 5.29
- GHI N/A
- 52 Week Low
- AQST $2.12
- GHI $10.12
- 52 Week High
- AQST $5.80
- GHI $15.27
- Technical
- Relative Strength Index (RSI)
- AQST 72.86
- GHI 44.40
- Support Level
- AQST $3.62
- GHI $11.51
- Resistance Level
- AQST $3.80
- GHI $12.00
- Average True Range (ATR)
- AQST 0.19
- GHI 0.35
- MACD
- AQST 0.05
- GHI -0.03
- Stochastic Oscillator
- AQST 95.43
- GHI 29.63
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests
Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.